BRIDGER MANAGEMENT LLC

Average Profitability
<0.0001%
Insider Buys Quantity
16
Insider Buys Sum
$17.13M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of BRIDGER MANAGEMENT LLC

The largest purchase of all time was on 2015-04-02 and amounted to 600000 shares of Cardiff Oncology, Inc. for $4.14M.

Biography of BRIDGER MANAGEMENT LLC

No biography is available at this moment.

2016-11-11PurchaseCardiff Oncology, Inc.
CRDF
644,944
2.1584%
$3.08$1.99M-68.52%
2015-07-17PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
280,000
0.9334%
$8.75$2.45M-43.31%
2015-04-02PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
600,000
2.3878%
$6.90$4.14M-15.74%
2015-02-27PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
158,686
0.7235%
$5.62$891,815+10.62%
2015-02-26PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
157,602
0.7067%
$5.42$854,203+12.73%
2015-02-25PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
210,284
0.9508%
$5.12$1.08M+20.33%
2015-02-06PurchaseCardiff Oncology, Inc.
CRDF
10 percent owner
888,888
4.1015%
$4.50$4M+39.82%
2008-04-14PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
19,880
0.0867%
$8.47$168,384-51.17%
2008-04-11PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
21,448
0.0908%
$8.45$181,236-52.21%
2008-04-10PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
4,922
0.0204%
$8.50$41,837-53.38%
2008-04-08PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
600
0.0023%
$8.48$5,088-53.25%
2008-04-07PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
53,694
0.229%
$8.66$464,990-45.71%
2008-04-04PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
3,000
0.0124%
$8.74$26,220-46.61%
2008-04-03PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
14,898
0.0626%
$8.75$130,358-45.59%
2008-04-02PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
81,558
0.3415%
$8.74$712,817-45.14%
2008-03-14PurchaseJazz Pharmaceuticals plc
JAZZ
10 percent owner
2
<0.0001%
$9.48$19-39.45%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.